April 25, 2008 -
Pfizer has entered into a collaboration agreement with four major research universities
– University of California, Santa Barbara (UCSB);
Caltech; the
Massachusetts Institute of Technology; and
University of Massachusetts – and
Entelos, a physiological modeling company, to re-examine the regulatory mechanisms of human energy metabolism.
Pfizer is funding the three-year and $14 million Insulin Resistance Pathway (IRP) Project to look at insulin signaling in adipose (fat) cells to increase understanding of diabetes and obesity, inextricably linked conditions that affect 7 percent of the U.S. population...
Pfizer's Press Release -
